Evidence map›Paper›PMID 37627847›Full record

ArticleBioengineering (Basel, Switzerland)2023

Establishing Compliance between Spectral, Colourimetric and Photometric Indicators in Resazurin Reduction Test.

Alexander V Sychev, Anastasia I Lavrova, Marine Z Dogonadze, Eugene B Postnikov

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexander V SychevResearch Center for Condensed Matter Physics, Kursk State University, Radishcheva St. 33, 305000 Kursk, Russia.ORCID 0000-0002-6116-6915
Anastasia I LavrovaSaint-Petersburg State Research Institute of Phthisiopulmonology, Lygovsky av. 2-4, 191036 Saint-Petersburg, Russia.ORCID 0000-0002-8969-535X
Marine Z DogonadzeSaint-Petersburg State Research Institute of Phthisiopulmonology, Lygovsky av. 2-4, 191036 Saint-Petersburg, Russia.ORCID 0000-0002-9161-466X
Eugene B PostnikovDepartment of Theoretical Physics, Kursk State University, Radishcheva St. 33, 305000 Kursk, Russia.ORCID 0000-0001-7904-1881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The resazurin reduction test is one of the basic tests for bacterial culture viability and drug resistance endorsed by the World Health Organisation. At the same time, conventional spectrophotometric and spectrofluorimetric methods demand rather bulky and expensive equipment. This induces a challenge for developing simpler approaches to sensor systems that are portable and applicable in resource-limited settings. In this work, we address two such alternative approaches, based on the colour processing of the microbiological plate's photographic images and single-channel photometry with a recently developed portable microbiological analyser. The key results consist of establishing a sequential linear correspondence between the concentration of resorufin produced due to the reduction of resazurin by viable bacteria as determined by the UV-Vis studies, the intensity of the a* channel of the CIE L*a*b* colour space and the transmitted light intensity registered by a luxmeter under the LED illumination with a yellow colour filter. This route is illustrated with the chemical system "Hydrazine hydrate - resazurin", isolating the target colour change-inducing reaction and the test of determining the minimal inhibition concentration of the antibacterial first-line drug isoniazid acting on the culture of the H37Rv strain of

Indexed as

microbiological analysisminimal inhibitory concentrationREMAresazurinresorufin

Identifiers

PMID37627847
PMCPMC10451944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.